A broad Italian experience with eribulin mesylate in metastatic breast cancer patients: The ESEMPiO study.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e11539-e11539 ◽  
Author(s):  
Sandro Barni ◽  
Caterina Fontanella ◽  
Lucia Del Mastro ◽  
Luca Livraghi ◽  
Laura Pizzuti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Eribulin Mesylate ◽  
Italian Experience

scholarly journals Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program

2019 ◽  
Vol 145 (12) ◽  
pp. 3359-3369 ◽  
Author(s):  
William Jacot ◽  
Pierre‐Etienne Heudel ◽  
Julien Fraisse ◽  
Sophie Gourgou ◽  
Séverine Guiu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Real Life ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Life Activity ◽  
Eribulin Mesylate

Eribulin mesylate in heavily pretreated metastatic breast cancer patients: current practice in an Italian community hospital

2014 ◽  
Vol 10 (2) ◽  
pp. 233-239 ◽  
Author(s):  
Paola Poletti ◽  
Valentina Ghilardi ◽  
Luca Livraghi ◽  
Laura Milesi ◽  
Elena Rota Caremoli ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Current Practice ◽  
Community Hospital ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Eribulin Mesylate ◽  
Heavily Pretreated ◽  
Italian Community
Sign in / Sign up

Export Citation Format

Share Document